Goally was founded with the mission to provide device-based behavioral therapy for children with ADHD or autism. The company's vision is to create a supportive environment that fosters independence and learning in neurodiverse children. Goally offers a specialized tablet designed for kids aged 2 to 10, which helps manage daily routines like bedtime and mornings with total parental control via a smartphone app. The device is free from web browsers, ads, and other potentially harmful content, focusing instead on aiding behavioral development and reducing stress for both children and parents.

Notable affiliates include a community of thousands of parents, educators, and therapists who support and celebrate neurodiversity. Goally has garnered significant attention for its innovative approach to behavioral therapy, providing a practical solution that integrates seamlessly into daily life. The company's impact is evident in the positive feedback from its user base, highlighting improvements in routine management and overall family well-being. Investors and stakeholders recognize Goally's potential to revolutionize behavioral therapy for neurodiverse children, making it a promising player in the health tech market.